Work

Development and Validation of Xenograft-Based Platform-Independent Gene Signatures That Predict Response to Alkylating Chemotherapy, Radiation, and Combination Therapy in Glioblastoma

Year: 2018

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2018.06.094

Authors: S.G. Zhao, P. Decker, D.E. Spratt, S.W.L. Chang, F.Y. Feng, M.M. Kim, C. Speers, J. Eckel-Passow, B. Carlson, A.C. Tuma, T.S. Lawrence, M. Yu, J.N. Sarkaria, D.R. Wahl

Institutions: University of Michigan, Mayo Clinic, University of California, San Francisco, University of California San Francisco Medical Center, Veterans Health Administration, VA Ann Arbor Healthcare System, Ann Arbor VA Medical Center, University of Wisconsin–Madison

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2896833070

FWCI:

Cites:

Cited by:

Related to: 10